BCR and prostate carcinoma: In another study, Li and colleagues examined the association between expression of Programmed Cell Death Protein 1 (PD1) and (Programmed Cell Death 1 Ligand 1) PD-L1 proteins with BCR in prostate cancer patients following adjuvant hormonal therapy (AHT) [86].